Senti Biosciences Holdings (SNTI) Revenue (2021 - 2023)
Senti Biosciences Holdings (SNTI) posted quarterly Revenue of $338000.0 for Q3 2023, down 77.7% year-over-year from $1.5 million in Q3 2022, and down 50.8% quarter-over-quarter from $687000.0 in Q2 2023.
Senti Biosciences Holdings (SNTI) Revenue (2021 - 2023) Analysis & Trends
Senti Biosciences Holdings' Revenue history runs 3 years deep, the most recent figure standing at $338000.0 for Q3 2023.
- In Q3 2023, Revenue fell 77.7% year-over-year to $338000.0; the TTM figure through Jun 2024 stood at $338000.0 (down 90.47% YoY), while the FY2025 annual figure was $22000.0, changed N/A from the prior year.
- Revenue for Q3 2023 stood at $338000.0, down from $687000.0 in the prior quarter.
- The five-year high for Revenue was $1.5 million in Q3 2022, with the low at $59000.0 in Q4 2022.
- The 3-year median for Revenue is $940500.0 (2021), against an average of $855200.0.
- Peak annual rise in Revenue reached 74.55% in 2022, while the deepest fall reached 81.73% in 2022.
- Senti Biosciences Holdings' Revenue stood at $323000.0 in 2021, then plunged by 81.73% to $59000.0 in 2022, then jumped by 472.88% to $338000.0 in 2023.
- Business Quant data shows SNTI's Revenue at $338000.0 in Q3 2023, $687000.0 in Q2 2023, and $1.3 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.29 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.06 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 425.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 674.14 Mn |
| 10 | Senti Biosciences Holdings | 12.06 Mn | 12.06 Mn | - | 17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 338,000.00 |
| Jun 30, 2023 | 687,000.00 |
| Mar 31, 2023 | 1.29 Mn |
| Dec 31, 2022 | 59,000.00 |
| Sep 30, 2022 | 1.52 Mn |
| Jun 30, 2022 | 1.36 Mn |
| Mar 31, 2022 | 1.10 Mn |
| Dec 31, 2021 | 323,000.00 |
| Sep 30, 2021 | 1.10 Mn |
| Jun 30, 2021 | 778,000.00 |